Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Repeated dose toxicity: oral

Currently viewing:

Administrative data

Endpoint:
short-term repeated dose toxicity: oral
Type of information:
experimental study
Adequacy of study:
supporting study
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
secondary literature
Cross-referenceopen allclose all
Reason / purpose for cross-reference:
reference to same study
Reference
Endpoint:
screening for reproductive / developmental toxicity
Type of information:
experimental study
Adequacy of study:
supporting study
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
secondary literature
Reason / purpose for cross-reference:
reference to same study
Reason / purpose for cross-reference:
reference to same study
Qualifier:
according to guideline
Guideline:
OECD Guideline 422 (Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test)
Deviations:
not specified
GLP compliance:
not specified
Limit test:
no
Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Route of administration:
oral: gavage
Vehicle:
corn oil
Analytical verification of doses or concentrations:
not specified
Duration of treatment / exposure:
Males were treated 42 days and females were treated for 14 days prior to mating to day 3 of lactation
Dose / conc.:
0 mg/kg bw/day
Dose / conc.:
100 mg/kg bw/day
Dose / conc.:
300 mg/kg bw/day
Dose / conc.:
1 000 mg/kg bw/day
No. of animals per sex per dose:
13 male and 13 female Sprague-Dawley rats per dose group
Control animals:
yes
NOAEL >= 1000 mg/kg bw/day; no treatment-related adverse effects observed in parental animals or offspring
Dose descriptor:
NOAEL
Effect level:
>= 1 000 mg/kg bw/day
Based on:
test mat.
Sex:
male/female
Basis for effect level:
clinical signs
NOAEL >= 1000 mg/kg bw/day; no treatment-related adverse effects observed in parental animals or offspring
Dose descriptor:
NOAEL
Generation:
F1
Effect level:
>= 1 000 mg/kg bw/day
Based on:
test mat.
Sex:
male/female
Basis for effect level:
other: Treatment-related adverse effects observed in offspring
Conclusions:
NOAEL >= 1000 mg/kg bw/day; no treatment-related adverse effects observed in parental animals or offspring
Executive summary:

A summary of an OECD 422 combined repeat dose and reproductive toxicity study on behenic acid (C22) is available in the safety assessment of fatty acids report by the Cosmetics Ingredients Review expert panel (CIR 2018). The data have been included as a Klimisch 4 supporting study as very limited details are available, however the data are taken from a peer-reviewed secondary source and are considered relevant for inclusion.

Reason / purpose for cross-reference:
reference to same study
Reference
Endpoint:
developmental toxicity
Type of information:
experimental study
Adequacy of study:
weight of evidence
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
secondary literature
Reason / purpose for cross-reference:
reference to same study
Reason / purpose for cross-reference:
reference to same study
Qualifier:
according to guideline
Guideline:
other: OECD 422
Deviations:
not specified
GLP compliance:
not specified
Remarks:
Published review document
Limit test:
no
Species:
rat
Strain:
Sprague-Dawley
Route of administration:
oral: gavage
Vehicle:
corn oil
Analytical verification of doses or concentrations:
not specified
Duration of test:
males were treated 42 days and females were treated for 14 days prior to mating to day 3 of lactation
Dose / conc.:
0 mg/kg bw/day
Dose / conc.:
100 mg/kg bw/day
Dose / conc.:
300 mg/kg bw/day
Dose / conc.:
1 000 mg/kg bw/day
No. of animals per sex per dose:
13 male and 13 female Sprague-Dawley rats per dose group
Control animals:
yes
Details on results:
NOAEL >= 1000 mg/kg bw/day; no treatment-related adverse effects observed in parental animals or offspring
Details on maternal toxic effects:
NOAEL >= 1000 mg/kg bw/day; no treatment-related adverse effects observed in parental animals or offspring
Dose descriptor:
NOAEL
Effect level:
>= 1 000 mg/kg bw/day
Based on:
test mat.
Basis for effect level:
clinical signs
Details on embryotoxic / teratogenic effects:
NOAEL >= 1000 mg/kg bw/day; no treatment-related adverse effects observed in parental animals or offspring
Dose descriptor:
NOAEL
Effect level:
>= 1 000 mg/kg bw/day
Based on:
test mat.
Sex:
not specified
Basis for effect level:
other: Treatment-related adverse effects observed for offspring
Developmental effects observed:
no
Lowest effective dose / conc.:
1 000 mg/kg bw/day
Treatment related:
not specified

NOAEL >= 1000 mg/kg bw/day; no treatment-related adverse effects observed in parental animals or offspring

Conclusions:
NOAEL >= 1000 mg/kg bw/day; no treatment-related adverse effects observed in parental animals or offspring
Executive summary:

A summary of a 28 day gavage study on behenic acid (C22) is available in the safety assessment of fatty acids report by the Cosmetics Ingredients Review expert panel (CIR 2018). The data have been included as a Klimisch 4 supporting study as very limited details are available, however the data are taken from a peer-reviewed secondary source and are considered relevant for inclusion.

Data source

Reference
Reference Type:
review article or handbook
Title:
Safety assessment of fatty acids and soaps as used in cosmetics
Author:
Cosmetics Ingredients Review Expert Panel
Year:
2018
Bibliographic source:
Scientific Literature Review for Public Comment, Cosmetic Ingredient Review, 1620 L St NW, Suite 1200, Washington, DC 20036-4702, USA
Report date:
2018

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 422 (Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test)
Deviations:
not specified
GLP compliance:
not specified
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Docosanoic acid
EC Number:
204-010-8
EC Name:
Docosanoic acid
Cas Number:
112-85-6
Molecular formula:
C22H44O2
IUPAC Name:
docosanoic acid
Test material form:
not specified

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
corn oil
Analytical verification of doses or concentrations:
not specified
Duration of treatment / exposure:
Males were treated 42 days and females were treated for 14 days prior to mating to day 3 of lactation
Doses / concentrationsopen allclose all
Dose / conc.:
0 mg/kg bw/day (nominal)
Dose / conc.:
100 mg/kg bw/day (nominal)
Dose / conc.:
300 mg/kg bw/day (nominal)
Dose / conc.:
1 000 mg/kg bw/day (nominal)
No. of animals per sex per dose:
13 male and 13 female Sprague-Dawley rats per dose group
Control animals:
yes

Results and discussion

Results of examinations

Details on results:
NOAEL >= 1000 mg/kg bw/day; no treatment-related adverse effects observed in parental animals or offspring

Effect levels

Dose descriptor:
NOAEL
Effect level:
>= 1 000 mg/kg bw/day (nominal)
Based on:
test mat.
Sex:
male/female
Basis for effect level:
other: treatment related effects in parental animals and offspring
Remarks on result:
not determinable due to absence of adverse toxic effects

Applicant's summary and conclusion

Conclusions:
NOAEL >= 1000 mg/kg bw/day; no treatment-related adverse effects observed in parental animals or offspring
Executive summary:

A summary of an OECD 422 combined repeat dose and reproductive toxicity study on behenic acid (C22) is available in the safety assessment of fatty acids report by the Cosmetics Ingredients Review expert panel (CIR 2018). The data have been included as a Klimisch 4 supporting study as very limited details are available, however the data are taken from a peer-reviewed secondary source and are considered relevant for inclusion.